It remains an unproven hypothesis. The revenue of the top 2-3 labs is still growing nearly exponentially, which is the ultimate piece of data that settles the question empirically for now. Benchmark scores aren't really proof. Benchmaxxing is possible, for example. Only revenue numbers (and gross margins) count.
It remains an unproven hypothesis. The revenue of the top 2-3 labs is still growing nearly exponentially, which is the ultimate piece of data that settles the question empirically for now. Benchmark scores aren't really proof. Benchmaxxing is possible, for example. Only revenue numbers (and gross margins) count.